683 Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-125,000
Closed -$11.4M 200
2020
Q4
$11.4M Sell
125,000
-100,000
-44% -$6.21M 0.72% 46
2020
Q3
$8.99M Hold
225,000
0.84% 40
2020
Q2
$7.72M Hold
225,000
0.78% 42
2020
Q1
$5M Hold
225,000
0.77% 42
2019
Q4
$4.4M Hold
225,000
0.7% 48
2019
Q3
$3.49M Sell
225,000
-75,000
-25% -$1.44M 0.58% 53
2019
Q2
$6.09M Sell
300,000
-95,000
-24% -$1.71M 0.79% 44
2019
Q1
$6.94M Sell
395,000
-10,000
-2% -$158K 0.93% 40
2018
Q4
$5.2M Sell
405,000
-244,800
-38% -$3.41M 0.77% 55
2018
Q3
$10.6M Sell
649,800
-94,211
-13% -$1.11M 1.32% 37
2018
Q2
$8.44M Sell
744,011
-249,700
-25% -$2.75M 1.1% 39
2018
Q1
$9.7M Buy
993,711
+139,911
+16% +$1.34M 1.44% 35
2017
Q4
$5.22M Buy
853,800
+175,000
+26% +$781K 0.83% 62
2017
Q3
$2.69M Buy
678,800
+90,563
+15% +$308K 0.48% 71
2017
Q2
$1.91M Buy
588,237
+118,237
+25% +$453K 0.4% 65
2017
Q1
$2.14M Buy
+470,000
New +$1.72M 0.5% 61

Other funds holding FATE